Last reviewed · How we verify
NCT04298268
The CUSA Clarity Soft Tissue Removal Study
trial testing CUSA Clarity Ultrasonic Surgical Aspirator System use in Benign, Malignant Tumors or Other Soft Tissue Removal in 100 participants. Completed in 24 November 2021.
24 November 2021
Quick facts
| Lead sponsor | Integra LifeSciences Corporation |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 30 March 2020 |
| Primary completion | 24 November 2021 |
| Estimated completion | 24 November 2021 |
| Sites | 5 locations across Italy, Germany |
Drugs / interventions tested
- CUSA Clarity Ultrasonic Surgical Aspirator System use
Conditions studied
- Benign, Malignant Tumors or Other Soft Tissue Removal — all drugs for Benign, Malignant Tumors or Other Soft Tissue Removal →
- Nephrectomy or Partial Nephrectomy With Parenchyma Removal — all drugs for Nephrectomy or Partial Nephrectomy With Parenchyma Removal →
Sponsor
Integra LifeSciences Corporation — full company profile →
Who can join
18 and older, any sex, with Benign, Malignant Tumors or Other Soft Tissue Removal or Nephrectomy or Partial Nephrectomy With Parenchyma Removal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To investigate the clinical performance and surgeon preferences of the CUSA® Clarity Ultrasonic Surgical Aspirator System for soft tissue removal during surgical procedures. This will be evaluated through the effectiveness of soft tissue removal per surgeon assessment and Incidence of Adverse Device Effects.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The CUSA Clarity Soft Tissue Removal Study: Clinical Performance Investigation of the CUSA Clarity Ultrasonic Surgical Aspirator System for Soft Tissue Removal During Liver Surgery.
Accardo C, Gruttadauria S, Decarlis L, Agnes S, et al · · 2024 · cited 2× · PMID 38294895 · DOI 10.1089/lap.2023.0467
Verify or expand the search:
- PubMed search for NCT04298268
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Integra LifeSciences Corporation trials
Trials by the same sponsor.
- NCT06760611 — Tissue Quality of Integra vs. BTM Treated Burns · withdrawn
- NCT06629506 — MicroMatrix® Flex in Tunneling Wounds · NA · completed
- NCT06453187 — A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers · NA · enrolling by invitation
- NCT06276543 — Bactiseal Catheter Safety Registry Study · recruiting
- NCT06297187 — Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04298268 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Integra LifeSciences Corporation
- Last refreshed: 8 February 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04298268.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing